Medical device company Integra LifeSciences (NASDAQ:IART) reported Q2 CY2025 results , but sales were flat year on year at ...

Integra Lifesciences Holdings Corp (NASDAQ:IART) is set to release its Q2 2025 earnings on Jul 31, 2025. The consensus ...

Medical device company Integra LifeSciences (NASDAQ:IART) will be reporting results this Thursday before market open. Here’s ...

Integra (IART) delivered earnings and revenue surprises of +4.65% and +5.05%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Integra LifeSciences (Nasdaq: IART) shares are on the rise today on second-quarter results that beat the consensus forecast.

For the current quarter ending in September, Integra expects its per-share earnings to range from 40 cents to 45 cents. The company said it expects revenue in the range of $410 million to $420 million ...

Integra LifeSciences Holdings Corporation (IART) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.

Another notable valuation metric for IART is its P/B ratio of 1.18. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus ...

Another notable valuation metric for IART is its P/B ratio of 1.28. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities.